Cormorant Asset Management’s ADARx Pharmaceuticals ADRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.2M Buy
+962,898
New +$19.3M 1.29% 24

Other funds holding ADRX

Cormorant Asset Management's ADRX Position: Q3 2026 in Review

Cormorant Asset Management opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 962,898 shares worth $19.2M. The stake represents 1.29% of the portfolio and ranks #24 among its holdings.

62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.

  • Cormorant Asset Management held 962,898 shares of ADARx Pharmaceuticals worth $19.2M as of Q3 2026.
  • ADARx Pharmaceuticals was a new Cormorant Asset Management position in Q3 2026.
  • ADARx Pharmaceuticals made up 1.29% of Cormorant Asset Management's portfolio in Q3 2026, its #24 holding.
  • 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.

Based on Cormorant Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.